lobbying_activities: 3007667

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3007667	a820664a-2958-4f3d-9b17-759e35c562c4	Q2	TARPLIN, DOWNS & YOUNG, LLC	304736	HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)	2023	second_quarter	PHA	Opioid Abuse - General issues related to opioid abuse and access to medication assisted treatment HR 501 Halt, Block, and Suspend Suspicious Orders HR 467 HALT Fentanyl Act HR 1770 - Equitable Community Access to Pharmacist Services Act Implementation of Public Law 113-54 (DSCSA)	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	80000		0	0	2023-07-17T15:25:14-04:00